ODTX

NASD Odyssey Therapeutics, Inc.

Nov 6, 2026 · 2:25 PM ET DELAYED Market Open

$19.26 ↑ +0.38 (+1.99%) Trading Up from the previous close of $18.88, $0.44 below the day’s high of $19.70

YTD change: +17.27%
vs 20-day SMA: +1.93%
vs 200-day SMA: N/A

Price ranges

Previous day

$18.32 $19.81

open $19.50 close $18.88

-$0.62 (-3.18%)

Today

$18.01 $19.70

open $18.99 now $19.26

+$0.27 (+1.40%)

Past week

$18.32 $22.36

from $19.83 now $19.26

-$0.57 (-2.90%)

Past month

$16.36 $22.36

from $18.12 now $19.26

+$1.14 (+6.26%)

This year

$15.10 $29.05

from $16.42 now $19.26

+$2.84 (+17.27%)

Price & Performance

+2.46 (+14.98%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 33.7% away from all-time highs of $29.05
ODTX is up 17% since the beginning of the year
ODTX is up 17% over the past 12 months
ODTX is up 6% over the past 1 month
17% of all ODTX investors are betting against ODTX

ODTX reads neutral: the 12-month move is +15.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-1.1

Earnings momentum -1.6% Quarterly EPS growth

Quarterly change -1.6%

Valuation

P/E ratio N/A

Enterprise value $602.6M

Beta 9.00

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$326.0M

Debt$23.5K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $925.5M

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$34.96	-0.40%
ARGX	argenx SE Sponsored ADR	$894.77	-3.93%
ONC	BeOne Medicines Ltd. Sponsored ADR	$387.25	+2.51%
WXXWY	WuXi Biologics (Cayman) Inc. Unsponsored ADR	$12.25	-1.84%
INCY	Incyte Corporation	$118.01	-3.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.